ARDS survival was significantly predicted by improvement in the P/F ratio in patients who underwent 3 periods of prone ...

Sepsis, a severe and often fatal complication of infection, is a leading cause of both ALI and acute respiratory distress ...

Healios KK (JP:4593) has released an update. Healios KK has made progress in its application for conditional approval of its MultiStem product for ...

EXO-CD24 is under clinical development by Nano24med and currently in Phase II for Acute Respiratory Distress Syndrome.